Key information made simple
This feasibility study is preparing to test whether people can tell if they received psilocybin or placebo when the treatment acts during sleep. The ISRCTN record lists the study as not yet recruiting.
Not Yet RecruitingISRCTN10648713
Sleep Blinding Psilocybin, a feasibility study: Examining if participants can tell if they received psilocybin or a placebo when medication is given to act in sleep
This study is not yet recruiting. It focuses on depression and currently lists study information in the United Kingdom.
DepressionOtherFrom 18 Years to 65 Years
Your next step
The public record does not provide enough detail to summarize the visit format or participation steps clearly. Check the official source for the exact eligibility criteria, locations, contact details, and current recruiting status before taking any next step.
Key study information
- Condition
- Depression; Mental and Behavioural Disorders
- Study status
- Not Yet Recruiting
- Sponsor / lead affiliation
- King's College London
- Location / country
- United Kingdom
- Registry
- ISRCTN
Why this study may matter
This study may matter because it adds public evidence around depression. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Registry reference
This page links back to the public source record so people can verify details directly with the registry and research team.
If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.
Open source recordAsk HopeStage to review this study with me
This form records your interest so HopeStage can follow up with practical guidance. It is not a medical eligibility decision and it does not guarantee a study spot.
Study reference: ISRCTN10648713. We only ask for your email here. HopeStage can help you review the study, but this is not a medical eligibility decision.
For you
Taking part may help improve understanding of your condition.
It requires a lighter follow-up, often with questionnaires or check-ins.
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Things to check before joining
- Sponsor
- King's College London
- Sponsor type
- University
- Main activity
- behavioral or lifestyle intervention
- Intervention
- Not available
- Time commitment
- multiple visits or assessments
- Study phase
- Not available
- Enrollment
- Not available
- Recruitment status
- Not Yet Recruiting
- Source
- Official registry link
Questions about this study
What is Sleep Blinding Psilocybin, a feasibility study: Examining if participants can tell if they received psilocybin or a placebo when medication is given to act in sleep?
This study is exploring behavioral or lifestyle intervention for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. It includes a comparison with placebo. Direct benefit is not guaranteed.
Who is behind this study, and what type of sponsor is it?
This study is sponsored by King's College London, a university. King’s College London is a university in the United Kingdom with health and medical research activity. The sponsor is based in the United Kingdom. Sponsor website: https://www.kcl.ac.uk. You can verify the sponsor and study responsibility in the official registry record.
What does participation involve, what phase is it, and what should I ask about safety?
This study may involve behavioral or lifestyle intervention, study visits, and assessments. The time commitment is multiple visits or assessments. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.
Where can I verify the study details?
Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.